The Potential of Gamma Secretase as a Therapeutic Target for Cardiac Diseases
Heart diseases are some of the most common and pressing threats to human health worldwide. The American Heart Association and the National Institute of Health jointly work to annually update data on cardiac diseases. In 2018, 126.9 million Americans were reported as having some form of cardiac disor...
Main Authors: | Sujoita Sen, Logan Hallee, Chi Keung Lam |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/12/1294 |
Similar Items
-
Presenilins and γ-Secretase in Membrane Proteostasis
by: Naoto Oikawa, et al.
Published: (2019-03-01) -
Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease
by: Gunnar Nordvall, et al.
Published: (2023-10-01) -
Active site geometry stabilization of a presenilin homolog by the lipid bilayer promotes intramembrane proteolysis
by: Lukas P Feilen, et al.
Published: (2022-05-01) -
Conformational Changes and Unfolding of β-Amyloid Substrates in the Active Site of γ-Secretase
by: Jakub Jakowiecki, et al.
Published: (2024-02-01) -
Analysis of Non-Amyloidogenic Mutations in APP Supports Loss of Function Hypothesis of Alzheimer’s Disease
by: Meewhi Kim, et al.
Published: (2023-01-01)